Technical Analysis for OPGN - OpGen, Inc.

Grade Last Price % Change Price Change
grade C 2.1 -2.33% -0.05
OPGN closed down 2.33 percent on Thursday, July 9, 2020, on 2.29 times normal volume. It was able to find support at its 50 day moving average.

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Strong Down Up Up
Historical OPGN trend table...

Date Alert Name Type % Chg
50 DMA Support Bullish 0.00%
Bollinger Band Squeeze Range Contraction 0.00%
BB Squeeze + Upper Band Touch Range Contraction 0.00%
Upper Bollinger Band Touch Strength 0.00%
20 DMA Support Bullish -2.33%
50 DMA Support Bullish -2.33%
New Uptrend Bullish -2.33%
Pocket Pivot Bullish Swing Setup -2.33%
Bollinger Band Squeeze Range Contraction -2.33%
BB Squeeze + Upper Band Touch Range Contraction -2.33%

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

OpGen, Inc. operates as an early commercial stage company using molecular testing and bioinformatics to assist healthcare providers to combat multi-drug-resistant bacterial infections. It offers Acuitas multi-drug-resistant organisms (MDRO) gene test, a molecular screening tool that detects 10 critical MDRO genes from 1 patient swab. The company also provides Acuitas CR Elite Test, which adds the ability to procure a standard microbiological culture result that provides additional information about the identified MDRO gene and its antibiotic susceptibility profile. In addition, it develops Acuitas Lighthouse MDRO bioinformatics product, which focuses on providing MDRO molecular information about an individual patient's resistance profile. OpGen, Inc. has a strategic collaboration with Hitachi High-Technologies Corporation to commercialize its genome mapping technology for mapping, assembly, and analysis of human DNA. The company was incorporated in 2001 and is headquartered in Gaithersburg, Maryland.
Health Healthcare Providers Pharmaceuticals Policy Antibiotic Bacteria Veterinary Medicine Antimicrobial Resistance Bioinformatics Evolutionary Biology Multi Drug Resistant Bacterial Infections

Is OPGN a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 12.8
52 Week Low 0.92
Average Volume 1,256,161
200-Day Moving Average 2.40
50-Day Moving Average 2.06
20-Day Moving Average 2.04
10-Day Moving Average 2.08
Average True Range 0.16
ADX 27.67
+DI 27.37
-DI 9.06
Chandelier Exit (Long, 3 ATRs ) 1.81
Chandelier Exit (Short, 3 ATRs ) 2.34
Upper Bollinger Band 2.15
Lower Bollinger Band 1.92
Percent B (%b) 0.78
BandWidth 11.19
MACD Line 0.01
MACD Signal Line 0.00
MACD Histogram 0.0132
Fundamentals Value
Market Cap 108.26 Million
Num Shares 51.6 Million
EPS -0.77
Price-to-Earnings (P/E) Ratio -2.73
Price-to-Sales 5.00
Price-to-Book 0.00
PEG Ratio 0.00
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 2.45
Resistance 3 (R3) 2.47 2.37 2.39
Resistance 2 (R2) 2.37 2.29 2.36 2.37
Resistance 1 (R1) 2.24 2.23 2.19 2.22 2.35
Pivot Point 2.14 2.14 2.12 2.13 2.14
Support 1 (S1) 2.01 2.06 1.96 1.99 1.85
Support 2 (S2) 1.91 2.00 1.90 1.83
Support 3 (S3) 1.78 1.91 1.81
Support 4 (S4) 1.76